Hematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningTransplantation, AutologousHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationTransplantation ChimeraRecurrenceBone Marrow TransplantationStem CellsTreatment OutcomeGraft vs Leukemia EffectRemission InductionTissue DonorsMyeloablative AgonistsBusulfanGraft vs Tumor EffectVidarabineGraft SurvivalHistocompatibility TestingLeukemia, Myeloid, AcuteRetrospective StudiesLeukemiaImmunosuppressive AgentsLymphocyte TransfusionCombined Modality TherapyMultiple MyelomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSalvage TherapyWhole-Body IrradiationSiblingsPrecursor Cell Lymphoblastic Leukemia-LymphomaCytomegalovirus InfectionsSurvival AnalysisCord Blood Stem Cell TransplantationDisease-Free SurvivalMinor Histocompatibility AntigensHematopoietic Stem CellsLymphocyte DepletionNeoplasm, ResidualSurvival RateMyelodysplastic SyndromesHistocompatibilityAntilymphocyte SerumLiver TransplantationVirus ActivationTime FactorsMelphalanChimerismAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideT-LymphocytesHepatic Veno-Occlusive DiseaseFollow-Up StudiesAcute DiseasePrognosisCytomegalovirusHematopoietic Stem Cell MobilizationMesenchymal Stem Cell TransplantationAnemia, AplasticHLA AntigensPrimary MyelofibrosisCell TransplantationHematologic DiseasesTransplantation ImmunologyLeukemia, Myeloid, Accelerated PhaseKidney TransplantationCytarabineImmunosuppressionAntigens, CD34Leukemia, MyeloidEmbryonic Stem CellsAntibodies, NeoplasmAntineoplastic AgentsHodgkin DiseaseBenzamidesFusion Proteins, bcr-ablRoseolovirus InfectionsImmunocompromised HostLymphoproliferative DisordersGraft RejectionAdult Stem CellsLymphoma, Non-HodgkinNuclear FamilyPyrimidinesTransplantation, IsogeneicLeukocyte TransfusionFatal OutcomeReceptors, Purinergic P2X5CyclosporineProspective StudiesGranulocyte Colony-Stimulating FactorInfectionGanciclovirImmunotherapy, AdoptivePiperazinesRisk FactorsFlow Cytometry